Latest news with #HoLEP
Associated Press
16-07-2025
- Health
- Associated Press
Boise Urologist Dr. Austen Slade Hosts Leading Physicians for Advanced Surgical Training
Boise's growing prominence in advanced urologic care was highlighted recently when Dr. Austen Slade welcomed visiting physicians from Stanford University and the University of Washington to observe and study the HoLEP (Holmium Laser Enucleation of the Prostate) procedure under his guidance. BOISE, ID / ACCESS Newswire / July 16, 2025 / The HoLEP procedure, a minimally invasive treatment for benign prostatic hyperplasia (BPH), is recognized for its effectiveness, reduced recovery time, and lower complication rates compared to traditional methods. Dr. Slade's expertise in this technique has positioned him as a national expert and key resource for urologists across the country seeking to enhance their skills in this innovative approach. Recognizing his expertise, patients from all over the United States and even foreign countries regularly travel to Boise seeking treatment under Dr. Slade's Austen Slade Demonstrates HoLEP Procedure Dr. Austen Slade demonstrates the HoLEP procedure at Treasure Valley Hospital as visiting surgeons from Stanford and the University of Washington observe. These procedures took place at Treasure Valley Hospital, one of the region's top surgical centers. The hospital was recently awarded the 2025 Outstanding Patient Experience Award by Healthgrades, placing it in the top 5% of hospitals nationwide for patient satisfaction. Treasure Valley Hospital exceeded the national average across all evaluated categories, demonstrating a consistent commitment to compassionate, high-quality care. The recent visits from esteemed academic institutions underscore Boise's emergence as a hub for cutting-edge men's health care. 'It is a privilege to share knowledge with colleagues from such distinguished programs,' said Dr. Slade. 'These exchanges reflect our shared commitment to advancing patient care and highlight Boise's role in shaping the future of urologic surgery.' Coinciding with Men's Health Month, this collaboration emphasizes the importance of raising awareness about BPH, a condition affecting millions of men over 50, and promoting access to state-of-the-art treatments. Dr. Slade's practice continues to provide Treasure Valley residents with world-class care, bringing advanced surgical options to the region. About Dr. Slade Dr. Austen Slade is a board-certified and fellowship-trained urologist specializing in advanced surgical techniques, including HoLEP, kidney stone treatment, and vasectomy. Based in Boise, Idaho, he is committed to delivering leading-edge care with a personalized approach for patients across the region. For more information, visit Contact InformationMary Valcich SEO Specialist (208) 514-1634 SOURCE: WebMarkets press release
Yahoo
05-03-2025
- Business
- Yahoo
Andromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical Development
First Surgical Robot Designed for Continuous Software Evolution—Initial Focus on HoLEP, with Expansion into Other Disease States SOUTH SAN FRANCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Andromeda Surgical, a leading innovator in robotic-assisted surgery, is proud to announce strategic partnerships with Richard Wolf and Quanta System, two global leaders in medical technology. These collaborations mark a major step forward in Andromeda's rapid development, reinforcing its mission to transform minimally invasive surgery with cutting-edge robotic solutions. Andromeda's robotic system is designed to be the first of its kind with constantly improving software, enabling continuous advancements in surgical precision, efficiency, and adaptability over time. This approach ensures that surgeons will always have access to the latest innovations without needing entirely new hardware. The system's first clinical application is Holmium Laser Enucleation of the Prostate (HoLEP), a gold-standard procedure for treating benign prostatic hyperplasia (BPH). However, Andromeda's technology is designed for scalability and will expand into multiple surgical specialties and disease states in the near future. Since launching its clinical program, Andromeda has already completed 15 successful procedures in Chile and New Zealand in its ASTRA clinical study, underscoring the company's rapid execution and real-world impact. Prof. Peter Gilling, a world-renowned urologist who pioneered the HoLEP procedure, is the lead principal investigator of the ASTRA Study. 'At Andromeda Surgical, we are moving at an unprecedented pace to redefine the future of robotic surgery,' said Nick Damiano, CEO & Co-founder of Andromeda Surgical. 'Partnering with Richard Wolf and Quanta System allows us to deliver a fully integrated solution that advances surgical precision and enhances patient outcomes. With a constantly improving software platform and an expanding range of clinical applications, we are building the future of surgical robotics.' Strategic Partnerships with Industry Leaders The collaboration with Richard Wolf, a pioneer in endoscopic imaging and surgical instrumentation, ensures that Andromeda's robotic system is optimized with best-in-class visualization technologies. 'Andromeda Surgical is bringing a groundbreaking approach to robotic-assisted surgery, and we are thrilled to be part of this journey,' said Jürgen Steinbeck, Co-CEO of Richard Wolf. 'Together, we will equip surgeons with the most advanced tools available, driving better patient care and expanding access to minimally invasive procedures.' The partnership with Quanta System, a global leader in laser technology, further strengthens Andromeda's capabilities. Quanta's holmium laser technology is integral to HoLEP, ensuring precise and efficient tissue removal. 'Our collaboration with Andromeda Surgical is a perfect match,' said Girolamo Lionetti, CEO of Quanta System. 'By integrating our laser technology with Andromeda's robotic platform, we are setting a new standard for HoLEP and paving the way for broader applications in surgical robotics.' A Bold Vision for the Future of Surgery Andromeda Surgical is committed to continuous software-driven evolution, ensuring its robotic system remains at the forefront of surgical innovation. With an initial focus on HoLEP and plans to expand into multiple surgical fields, Andromeda is well-positioned to reshape the landscape of robotic-assisted surgery. About Andromeda SurgicalAndromeda Surgical is a South San Francisco, California-based company developing autonomous surgical robots, starting with endourology procedures. The company's vision is to make the difficult parts of surgery easy and empower every surgeon to deliver optimal patient outcomes in every procedure. The team combines expertise from medtech, autonomous vehicles, and other robotics and AI applications, working in conjunction with top global urologists. About Richard WolfRichard Wolf is a full-service provider in endoscopy, offering a wide range of instrumentation and system solutions for minimally invasive medicine. With more than 16 subsidiaries and 130 distributors, Richard Wolf meets the needs of surgeons, medical professionals and patients with high-quality, precision endoscopic instruments. For more information, please visit About Quanta SystemFounded in 1985, Quanta System, a 100% Italian company part of SpA, has been a global leader for 40 years in designing cutting-edge laser systems and gold standard solutions for surgery, dermatology, and aesthetics. By the side of professionals and doctors pursuing its sole aim: improving patient care. Andromeda Surgical Media Contact:info@ in to access your portfolio
